MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
Das könnte Ihnen auch gefallen
Gewinner
Neueste Krypto-Nachrichten
Cysic Foundation: Airdrop-Berechtigungsprüfungstool jetzt live
WSJ: Investoren scheuen eine neue Runde des "Kryptowinters"
Aethir veröffentlicht 12-Monats-Zukunftsfahrplan zur Beschleunigung des Wachstums im globalen Enterprise AI Computing Business
24-Stunden Spot Funding Zu-/Abflussliste: ETH Nettoabfluss von 126 Mio. $, ZEC Nettoabfluss von 18,2 Mio. $
Bloomberg: Fed spaltet sich bei langfristiger Zinsstrategie nie so sehr
Kundenservice:@weikecs
Geschäftliche Zusammenarbeit:@weikecs
Quant-Trading & MM:[email protected]
VIP-Services:[email protected]